(Q37381770)

20 August 2017

1 reference

title

Purinergic receptor-mediated effects of adenosine 5'-triphosphate in urological malignant diseases (English)

1 reference

20 August 2017

main subject

adenosine triphosphate

0 references

2

Geoffrey Burnstock

1 reference

20 August 2017

Majid Shabbir

1

1 reference

20 August 2017

publication date

4 December 2008

1 reference

International Journal of Urology

20 August 2017

published in

1 reference

20 August 2017

volume

16

1 reference

20 August 2017

issue

2

1 reference

20 August 2017

page(s)

143-150

1 reference

20 August 2017

cites work

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

Cellular distribution and functions of P2 receptor subtypes in different systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

Pathophysiology and therapeutic potential of purinergic signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

Purine-mediated signalling in pain and visceral perception

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

Physiology and pathophysiology of purinergic neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

Purinergic signalling: pathophysiological roles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

P2-purinergic receptor agonists inhibit the growth of androgen-independent prostate carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

The liberation of adenosine triphosphate on antidromic stimulation of sensory nerves

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non-adrenergic inhibitory nerves in the gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

Atropine resistant excitation of the urinary bladder: the possibility of transmission via nerves releasing a purine nucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

Do some nerve cells release more than one transmitter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

Is there a basis for distinguishing two types of P2-purinoceptor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

Purinoceptors: are there families of P2X and P2Y purinoceptors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

Molecular physiology of P2X receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

Purine and pyrimidine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

Adenosine and adenine nucleotides are mitogenic for mouse thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

Role of the purinergic P2Z receptor in spontaneous cell death in J774 macrophage cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

Dr. Jekyll/Mr. Hyde: the dual role of extracellular ATP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

ATP regulates the differentiation of mammalian skeletal muscle by activation of a P2X5 receptor on satellite cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

Expression of functional P2-purinergic receptors in primary cultures of human colorectal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

Extracellular nucleotides inhibit growth of human oesophageal cancer cells via P2Y(2)-receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

Expression of purinergic receptors in non-melanoma skin cancers and their functional roles in A431 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

ATP- and UTP-activated P2Y receptors differently regulate proliferation of human lung epithelial tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

P2X7 receptor-mediated apoptosis of human cervical epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

P2Y purinergic receptors regulate the growth of human melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

21 January 2018

P2 receptors and cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

21 January 2018

Cancer statistics, 2003.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

Coincidence of bladder and prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

Transitional cell neoplasms of the urinary bladder. Can biologic potential be predicted from histologic grading?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

Effects of extracellular nucleotides and nucleosides on prostate carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

Characterization of calcium-independent purinergic receptor-mediated apoptosis in hormone-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

Activation of the P2Z/P2X7 receptor in human lymphocytes produces a delayed permeability lesion: involvement of phospholipase D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

A Thr357 to Ser polymorphism in homozygous and compound heterozygous subjects causes absent or reduced P2X7 function and impairs ATP-induced mycobacterial killing by macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

Early prostate cancer detected using expression of non-functional cytolytic P2X7 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

"Thymineless" death in androgen-independent prostatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

Mechanisms of ATP-induced calcium signaling and growth arrest in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

Calcium ionophore, ionomycin inhibits growth of human bladder cancer cells both in vitro and in vivo with alteration of Bcl-2 and Bax expression levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

Effect of extracellular ATP on the growth of hormone-refractory prostate cancer in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

Bisphosphonate-induced ATP analog formation and its effect on inhibition of cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

Extracellular nucleotides act through P2X7 receptors to activate NF-kappaB in osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

Pharmacokinetics of intravenous ATP in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

Randomized clinical trial of adenosine 5'-triphosphate in patients with advanced non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

Anticancer activities of adenine nucleotides in mice are mediated through expansion of erythrocyte ATP pools.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

Randomized clinical trial of adenosine 5′-triphosphate on tumor growth and survival in advanced lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02207.X

10.1111/J.1442-2042.2008.02207.X

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference